Entos (now Iambic) Included in Business Insider's List of Most-Promising Healthcare Start-Ups of 2023
Press
This is some text inside of a div block.
July 19, 2023
Related announcements
Iambic Therapeutics Announces the Addition of Shalini Sharp to its Board of Directors
Iambic Therapeutics Announces the Addition of Shalini Sharp to its Board of Directors
Iambic to Present New Pre-Clinical NSCLC Data for IAM1363, a Selective Type II Inhibitor for HER2 Cancers, at the 2025 World Conference on Lung Cancer
